EUVIMEDAtrasti EUVIMED
Open access

REELIN-COLBOS (H3447R) in Colombian oldest-old individuals, a case series

Daniel Vasquez, David Aguillon, Paula Perez Corredor, Diana Paola Alzate Echeverri, Yesica Zuluaga, Ana Y Baena, Lucia Madrigal, Liliana Hincapié, Liliana Ramirez Gomez, Lusiana Martinez, Vincent Malotaux, Francisco Lopera and 2 more

ScienceBank · 2025

DOI: 10.61340/rccoop ↗

At a glance

Journal article in ScienceBank, 2025. Written by Daniel Vasquez and 13 co-authors. Institution: Grupo de Neurociencias de Antioquia, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia. 30 references. The full text is freely available in PubMed Central. Funded by: NINDS NIH HHS.

SantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

We previously identified REELIN-COLBOS (RELN H3447R) and APOE Christchurch (APOE R136S) as candidate gene variants associated with protection against dementia in cases at the highest risk of Alzheimer’s Disease (AD) due to the PSEN1 E280A mutation in Colombia. Here, we examined the frequency of these variants in a cohort of 135 Colombian oldest-old individuals, part of the Resist AD Project. Five carriers of the REELIN-COLBOS variant were identified and described here, whereas none of the cases carried APOE Christchurch. The first case is a 102-year-old APOE4/E3 carrier with stable performance on cognitive tests despite having suffered an episode of delirium due to pneumonia. FDG-PET revealed relatively preserved cortical glucose metabolism despite showing degenerative changes on MRI. Another case with a family history of early-onset dementia maintained independence until age 85. Despite significant comorbidities, the other three cases exhibited preserved cognition at baseline. These observations are consistent with the hypothesis that the Reelin-COLBOS variant may play a protective role against cognitive decline and support healthy aging, although further studies are needed in larger and more diverse populations to confirm this association.

Subjects

Author keywords

AgingApolipoprotein ECase seriesCentenariansGenetic Predisposition to DiseaseReelin

Authors and institutions

  • Grupo de Neurociencias de Antioquia, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia.
  • Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School.
  • Massachusetts General Hospital, Harvard Medical School. Boston, MA, USA.
  • Department of Psychological & Brain Sciences, Boston University, Boston, MA, USA.

Funding

  • NINDS NIH HHS

Cite

APA

Vasquez, D., Aguillon, D., Corredor, P. P., Echeverri, D. P. A., Zuluaga, Y., Baena, A. Y., Madrigal, L., Hincapié, L., Gomez, L. R., Martinez, L., Malotaux, V., Lopera, F., Quiroz, Y. T., & Arboleda-Velasquez, J. F. (2025). REELIN-COLBOS (H3447R) in Colombian oldest-old individuals, a case series. ScienceBank. https://doi.org/10.61340/rccoop

Vancouver

Vasquez D, Aguillon D, Corredor PP, Echeverri DPA, Zuluaga Y, Baena AY, et al. REELIN-COLBOS (H3447R) in Colombian oldest-old individuals, a case series. ScienceBank. 2025. doi:10.61340/rccoop

BibTeX
@article{Vasquez2025,
  author = {Vasquez, Daniel and Aguillon, David and Corredor, Paula Perez and Echeverri, Diana Paola Alzate and Zuluaga, Yesica and Baena, Ana Y and Madrigal, Lucia and Hincapié, Liliana and Gomez, Liliana Ramirez and Martinez, Lusiana and Malotaux, Vincent and Lopera, Francisco and Quiroz, Yakeel T and Arboleda-Velasquez, Joseph F},
  title = {REELIN-COLBOS (H3447R) in Colombian oldest-old individuals, a case series},
  journal = {ScienceBank},
  year = {2025},
  doi = {10.61340/rccoop}
}
Start for free →